Cibc Private Wealth Group, LLC Corbus Pharmaceuticals Holdings, Inc. Transaction History

Cibc Private Wealth Group, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2018 Nov 14, 2018	SELL	$4.65 - $7.95 $232 - $397	-50 Closed	0 $0
Q1 2018 May 17, 2018	SELL	$5.6 - $9.25 $814,800 - $1.35 Million	-145,500 Reduced 99.97%	50 $0
Q4 2017 Feb 12, 2018	BUY	$6.6 - $7.78 $13,530 - $15,949	2,050 Added 1.43%	145,550 $1.03 Million
Q2 2017 Aug 09, 2017	BUY	N/A	143,500	143,500 $904,000

38.7K

Ticker CRBP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 125,268,000
Market Cap $2.19B
Description
Corbus Pharmaceuticals Holdings, Inc., a biopharmaceutical company, focuses on the development of immune modulators for immuno-oncology and fibrosis diseases. It develops lenabasum, an oral molecule that selectively activates cannabinoid receptor type 2 (CB2), which is in Phase II clinical trial to treat systemic lupus erythematosus; CRB-601, an...

Get notified when there are updates to the investment portfolio of Cibc Private Wealth Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Cibc Private Wealth Group, LLC with notifications on news.